You are here

Article info

Article menu
Immunotherapy biomarkers
Original research
T-cell tolerant fraction as a predictor of immune-related adverse events

Authors

  • Jared Ostmeyer Peter O’Donnell School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Jason Y Park Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Mitchell S von Itzstein Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • David Hsiehchen Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USAHarold C Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Farjana Fattah Harold C Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Mary Gwin Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Rodrigo Catalan Harold C Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Shaheen Khan Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Prithvi Raj Department of Immunology, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Edward K Wakeland Department of Immunology, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Yang Xie Peter O’Donnell School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USAHarold C Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • David E Gerber Peter O’Donnell School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USADepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USAHarold C Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles

Citation

Ostmeyer J, Park JY, von Itzstein MS, et al
T-cell tolerant fraction as a predictor of immune-related adverse events
Journal for ImmunoTherapy of Cancer 2023;11:e006437. doi: 10.1136/jitc-2022-006437
Online issue publication 
August 13, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.